Physician profile
Igor Prus
NPI 1205199502
$1,992.42
in general payments reported to CMS, 2019-2025
18 companies · $63.83 in 2025
The $63.83 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $210 · 2021: $266 · 2022: $158 · 2023: $765 · 2024: $282 · 2025: $63.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $581 · Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $581.33 |
| Food and Beverage | $529.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $845.76 | 2023-2024 | Iovera, Exparel, Zilretta |
| Pacira Therapeutics, INC. | $195.42 | 2019-2021 | |
| Pfizer INC. | $134.55 | 2019-2025 | |
| Bioventus LLC | $133.16 | 2020-2025 | Xcell |
| Horizon Therapeutics Plc | $90.46 | 2019-2023 | Krystexxa |
| Ferring Pharmaceuticals INC. | $83.69 | 2019-2021 | |
| Orthofix Medical, INC. | $80.48 | 2019-2024 | Physio-Stim |
| Heraeus Medical, LLC. | $69.70 | 2021-2022 | |
| Depuy Synthes Sales INC. | $66.84 | 2019-2024 | Orthovisc, Monovisc |
| Tenex Health INC. | $58.17 | 2021 | |
| Allergan, INC. | $44.31 | 2020 | |
| Smith+Nephew, INC. | $37.48 | 2021-2022 | |
| Organogenesis INC. | $36.18 | 2021-2022 | |
| Djo, LLC | $32.82 | 2023 | Cmf |
| Vertex Pharmaceuticals Incorporated | $27.86 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $23.93 | 2019 | |
| Amgen INC. | $19.45 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Prus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.